Academic and clinical adoption The COGNISION system is already used in academic, clinical, and pharmaceutical studies worldwide, indicating a ready base for expanding enterprise sales into hospitals, university research centers, and contract research organizations.

Noninvasive neurodiagnostics Position the system as a noninvasive cognitive testing solution for Alzheimer's, ADHD and related disorders to appeal to clinicians seeking efficient, patient-friendly tools to augment diagnosis and treatment planning.

Defense and field use US Army usage in Afghanistan demonstrates robustness and real-world reliability; explore partnerships or demonstrations with military medical programs or veteran healthcare initiatives as a pathway to broader adoption.

Scale and partnerships With a lean team and revenue in the low millions, there is an opportunity to pursue channel partnerships with larger neurotech players or contract research organizations to accelerate market penetration.

Data and outcomes focus Leverage the system’s cognitive testing data to offer outcome analytics and longitudinal tracking services, creating value propositions for pharma sponsors, clinics, and academic partners interested in measurable cognitive endpoints.